RHUMBLINE ADVISERS - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,807,312
-35.5%
19,223
+2.0%
0.00%
-40.0%
Q2 2023$4,353,888
+102561.8%
18,848
+7.7%
0.01%0.0%
Q1 2023$4,241
-15.6%
17,507
+1.1%
0.01%
-28.6%
Q4 2022$5,027
-99.5%
17,319
+5.7%
0.01%
+250.0%
Q3 2022$1,064,000
-3.4%
16,379
+6.4%
0.00%0.0%
Q2 2022$1,102,000
-9.4%
15,396
+24.2%
0.00%0.0%
Q1 2022$1,216,000
+20.2%
12,393
+3.8%
0.00%
+100.0%
Q4 2021$1,012,000
+4.8%
11,942
-1.4%
0.00%0.0%
Q3 2021$966,000
-16.5%
12,113
+2.0%
0.00%
-50.0%
Q2 2021$1,157,000
-5.1%
11,879
+13.9%
0.00%0.0%
Q1 2021$1,219,000
-3.3%
10,425
-8.0%
0.00%0.0%
Q4 2020$1,260,000
-4.9%
11,336
+1.6%
0.00%0.0%
Q3 2020$1,325,000
-13.5%
11,162
-17.5%
0.00%
-33.3%
Q2 2020$1,532,000
+99.7%
13,530
+17.7%
0.00%
+50.0%
Q1 2020$767,000
-21.9%
11,494
+6.6%
0.00%0.0%
Q4 2019$982,000
+12.0%
10,779
+5.9%
0.00%0.0%
Q3 2019$877,000
-17.5%
10,176
+0.4%
0.00%0.0%
Q2 2019$1,063,000
-6.8%
10,140
+11.3%
0.00%0.0%
Q1 2019$1,141,000
+9.1%
9,110
-1.8%
0.00%0.0%
Q4 2018$1,046,000
-20.2%
9,279
+51.5%
0.00%
-33.3%
Q3 2018$1,311,000
-17.7%
6,123
+7.5%
0.00%0.0%
Q2 2018$1,593,000
+229.1%
5,694
+37.4%
0.00%
+200.0%
Q1 2018$484,000
+57.7%
4,143
+24.0%
0.00%0.0%
Q4 2017$307,0003,3420.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders